These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 11100350)

  • 1. Twelve-month interferon-alpha therapy induces a similar sustained response in anti-HBe-positive and HBeAg-positive chronic hepatitis B patients.
    Fernández I; Castellano G; Manzano ML; Colina F; Canga F; Muñoz R; Fuertes A; Solís JA
    Hepatogastroenterology; 2000; 47(35):1351-5. PubMed ID: 11100350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon.
    Oliveri F; Santantonio T; Bellati G; Colombatto P; Mels GC; Carriero L; Dastoli G; Pastore G; Ideo G; Bonino F; Brunetto MR
    Am J Gastroenterol; 1999 May; 94(5):1366-72. PubMed ID: 10235220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Efficacy of interferon-alpha therapy for HBeAg-negative chronic hepatitis B and its influencing factors].
    Mao QG; Luo KX; Fu QF; Feng XR; Guo YB; Zhu YF; Peng J; Hou JJ
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):582-4. PubMed ID: 15504285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant interferon-alpha 2a hastens the rate of HBeAg clearance in children with chronic hepatitis B.
    Barbera C; Bortolotti F; Crivellaro C; Coscia A; Zancan L; Cadrobbi P; Nebbia G; Pillan MN; Lepore L; Parrella T
    Hepatology; 1994 Aug; 20(2):287-90. PubMed ID: 8045488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled trial of a 24-month course of interferon alfa 2b in patients with chronic hepatitis B who had hepatitis B virus DNA without hepatitis B e antigen in serum.
    Lampertico P; Del Ninno E; Manzin A; Donato MF; Rumi MG; Lunghi G; Morabito A; Clementi M; Colombo M
    Hepatology; 1997 Dec; 26(6):1621-5. PubMed ID: 9398007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study of the relapse of patients with chronic hepatitis B undergoing first and repeated recombinant interferon-alpha therapy during long-term follow up].
    Liu DL; Luo KX; Feng XR; Fu QX; Hou JL
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(26):1840-3. PubMed ID: 17922996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and virological characteristics of chronic hepatitis B with concurrent hepatitis B E antigen and antibody detection.
    Wang J; Zhou B; Lai Q; Wang Y; Shen G; Wang Z; Chen J; Hou J
    J Viral Hepat; 2011 Sep; 18(9):646-52. PubMed ID: 20636332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic carriers of hepatitis B virus in Bangladesh: a comparative analysis of HBV-DNA, HBeAg/anti-HBe, and liver function tests.
    Hasan KN; Rumi MA; Hasanat MA; Azam MG; Ahmed S; Salam MA; Islam LN; Hassan MS
    Southeast Asian J Trop Med Public Health; 2002 Mar; 33(1):110-7. PubMed ID: 12118438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP).
    Carreño V; Marcellin P; Hadziyannis S; Salmerón J; Diago M; Kitis GE; Vafiadis I; Schalm SW; Zahm F; Manzarbeitia F; Jiménez FJ; Quiroga JA
    Hepatology; 1999 Jul; 30(1):277-82. PubMed ID: 10385667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HBeAg seroconversion in children infected during early childhood with hepatitis B virus.
    Roushan MR; Bijani A; Ramzaninejad S; Roushan MH; Amiri MJ; Baiani M
    J Clin Virol; 2012 Sep; 55(1):30-3. PubMed ID: 22727680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective randomized controlled trial of sequential treatment with corticoids and alpha-interferon versus treatment with interferon alone in patients with chronic active hepatitis B.
    Niederau C; Heintges T; Niederau M; Stremmel W; Strohmeyer G
    Eur J Med; 1992 Nov; 1(7):396-402. PubMed ID: 1341478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon therapy of Turkish patients with chronic hepatitis B virus infection.
    Besirbellioglu B; Gul C; Gorenek L; Eyigun CP; Hacibektasoglu A; Van Thiel DH
    Hepatogastroenterology; 1999; 46(25):387-90. PubMed ID: 10228827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B.
    Andreone P; Cursaro C; Gramenzi A; Zavagliz C; Rezakovic I; Altomare E; Severini R; Franzone JS; Albano O; Ideo G; Bernardi M; Gasbarrini G
    Hepatology; 1996 Oct; 24(4):774-7. PubMed ID: 8855175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination thymosin-alpha 1 and interferon-alpha 2b in the treatment of anti-HBe-positive chronic hepatitis B in Turkey.
    Saruc M; Yuceyar H; Kucukmetin N; Demir MA; Kandiloglu AR
    Hepatogastroenterology; 2002; 49(45):798-802. PubMed ID: 12063993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative assessment of serum IgM anti-HBc in the natural course and during interferon treatment of chronic hepatitis B virus infection.
    Marinos G; Smith HM; Naoumov NV; Williams R
    Hepatology; 1994 Feb; 19(2):303-11. PubMed ID: 8294088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic HBV infection. Immunomodulation with levamisole in viremic HBeAg positive or anti-HBe positive patients--a pilot study.
    Krastev Z; Jelev D; Antonov K; Alagozian V; Kotzev I
    Hepatogastroenterology; 1999; 46(30):3184-8. PubMed ID: 10626183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative detection of intrahepatic hepatitis B virus DNA in patients with chronic hepatitis B].
    Lu H; Ma LX; Xu WS; Zhang HY; Yu LJ; Duan HY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):173-5. PubMed ID: 12681068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
    Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
    Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.